Bruker Corporation (BRKR) delivered adjusted earnings per share (EPS) of 52 cents in the second quarter of 2024, up 4% year over year. The figure came in line with the Zacks Consensus Estimate. The adjustments include expenses related to the amortization of purchased intangibles, acquisition-related costs and restructuring costs, among others. GAAP EPS was 5 cents compared with 39 cents in the year-ago period. Revenues in Detail Bruker registered revenues of $800.7 million in the second quarter, up 17.4% ye ...

For the quarter ended June 2024, Bruker (BRKR) reported revenue of $800.7 million, up 17.4% over the same period last year. EPS came in at $0.52, compared to $0.50 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $796.23 million, representing a surprise of +0.56%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.52. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they comp ...

Investors in Bruker Corporation (BRKR) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 20, 2024 $50 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could als ...

Bruker (BRKR) came out with quarterly earnings of $0.52 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.50 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this scientific equipment maker would post earnings of $0.46 per share when it actually produced earnings of $0.53, delivering a surprise of 15.22%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Bruker, which be ...

Exhibit 99.1 Bruker Reports Second Quarter 2024 Financial Results • Q2 2024 revenues of $800.7 million, up 17.4% year-over-year (yoy); organic revenue up 7.4% yoy; CER revenue up 18.5% yoy • Q2 2024 GAAP EPS $0.05; non-GAAP EPS $0.52, up 4.0% yoy • Bruker increases FY 2024 revenue guidance to $3.38-$3.44 billion, now including the NanoString business; implies revenue growth of 14% to 16%, and organic revenue growth of 5% to 7% yoy BILLERICA, Massachusetts – August 6, 2024 – Bruker Corporation (Nasdaq: BRKR) ...

For Immediate Release Chicago, IL – August 6, 2024 – Today, Zacks Equity Research discusses Mettler-Toledo International (MTD) and Bruker (BRKR) . Industry: Instruments – Scientific Link: https://www.zacks.com/commentary/2316245/2-instruments-stocks-to-watch-from-a-prospering-industry 2 Instruments Stocks to Watch From a Prospering Industry The Zacks Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by aging demography, and continued innovation in the pharma and lif ...

The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move lower. Zacks Consensus Estimate Revenues are expected to be $796.23 million, up 16.8% from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Earnings Whisper The Zacks ...

Bruker's (BRKR) strong growth reflects its fundamental commitment to innovate high-value solutions and the ongoing portfolio transformation. Yet, the company's operations bear the brunt of excessive currency exposure and general macroeconomic headwinds. The stock carries a Zacks Rank #3 (Hold) at present. The CALID segment has been gaining from the strong demand for differentiated instruments, particularly life science mass spectrometry proteomics solutions and optics spectroscopy and microscopy instruments ...

Hims & Hers Heath stock has surged 181.7% in the past year. Estimates for the company's earnings have increased from 18 cents to 19 cents for 2024 and from 33 cents to 35 cents for 2025 in the past 30 days. On the flip side, Bruker generates a substantial portion of its revenues in the international markets, primarily in Germany and other countries in the European Union, Switzerland and Japan. As a result, currency fluctuations continue to result in foreign currency transaction losses at the company. In add ...

Business leaders often talk about thinking big. But when it comes to nanotech stocks, the future is all about focusing on the small things. In terms of hard numbers, the global nanotech market reached a valuation of $3.69 billion in 2022. By 2030, the ecosystem could be worth $36.85 billion, or a compound annual growth rate (CAGR) of 33.1%. With projected expansion like that, it pays to at least consider these nanotech stocks. To be sure, VECO stock has already enjoyed a robust performance so far this year. ...